Dosage form: Vial

Specification: 1MIU /ml, 3 MIU/ml, 5 MIU/ml;

Indications: KINFERON® is indicated to treat the followingdiseases: Acute or chronic viral hepatitis (Type B, Type C, etc.),herpes zoster, condylomata acuminate, hairy cell leukemia, chronicmyelogenous leukemia, multiple myeloma, non-Hodgkin’s lymphoma,malignant melanoma, renal cell carcinoma, laryngeal papillomatosis,Kaposi’s sarcoma, ovary carcinoma, basal cell carcinoma, surfacebladder carcinoma, etc.